AVITA Medical (RCEL) Current Leases (2021 - 2023)

AVITA Medical (RCEL) posted Current Leases of $895000.0 for Q4 2023, up 46.24% on a QoQ basis from $612000.0 in Q4 2022, and up 46.24% year-over-year from $612000.0 in Q4 2022.

AVITA Medical (RCEL) Current Leases (2021 - 2023) Analysis & Trends

AVITA Medical's Current Leases history runs 3 years deep, the most recent figure standing at $895000.0 for Q4 2023.

  • Quarterly Current Leases rose 46.24% year-over-year to $895000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $895000.0 (up 46.24% YoY) and the FY2023 annual result came in at $895000.0, up 46.24% from the prior year.
  • Current Leases was $895000.0 for Q4 2023 at AVITA Medical, up from $612000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $895000.0 in Q4 2023 and bottomed at $612000.0 in Q4 2022.
  • A 3-year average of $726200.0 and a median of $702000.0 in 2021 frame the typical range for Current Leases.
  • Annual changes were most pronounced in 2022 — Current Leases declined 15.0% — and 2023, when it jumped 46.24%.
  • AVITA Medical's Current Leases stood at $720000.0 in 2021, then decreased by 15.0% to $612000.0 in 2022, then soared by 46.24% to $895000.0 in 2023.
  • Business Quant data shows RCEL's Current Leases at $895000.0 in Q4 2023, $612000.0 in Q4 2022, and $702000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 24.30 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 20.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 AVITA Medical 140.94 Mn 124.59 Mn 14.31 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 895,000.00
Dec 31, 2022 612,000.00
Sep 30, 2022 702,000.00
Dec 31, 2021 720,000.00
Jun 30, 2021 702,000.00